Paydirt
SGMT
Ticker

Sagimet Biosciences Inc.

SGMT · Healthcare · Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibit…

Sagimet Biosciences Inc. (SGMT), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 5 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 14 and filed Aug 17. The most active filer was George Kemble with 4 filings.

Add to watchlist
Filings, ttm
5
0 buys · 5 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$4.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 14
Filed Aug 17
ADViAverage daily dollar volume
$12.5M
market data
Share price · 12M
$8.26 (+21.3%)
$9.14$6.85$4.55Sep 22 2025Feb 27Aug 5

Adjusted for splits and dividends.

Volume by month
$3.8M$1.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Jul 2025 · sells $598KNov 2025 · sells $290KJul 2026 · sells $638KAug 2026 · sells $3.8M
Buys $0 Sells $5.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
GK George Kemble Executive Chairman 4 filings DH David Happel President & CEO 2 filings
Recent filings
George KembleSALE Director $3.6M
350,987 sh × $10.23
Exec Aug 14
Filed Aug 17 · 4:05 PM ET George KembleSALE Director $201K
20,206 sh × $9.95
Exec Aug 11
Filed Aug 12 · 7:41 PM ET David HappelSALE President & CEO $497K
64,051 sh × $7.76
Exec Jul 20
Filed Jul 22 · 4:05 PM ET George KembleSALE Director $141K
18,844 sh × $7.46
Exec Jul 20
Filed Jul 22 · 4:05 PM ET George KembleSALE Executive Chairman $290K
37,688 sh × $7.69
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET David HappelSALE President & CEO $598K
65,478 sh × $9.13
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET